Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation.
Thomas A MavrakanasKatherine GarloDavid M CharytanPublished in: Clinical journal of the American Society of Nephrology : CJASN (2020)
This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_05_29_CJN11650919.mp3.
Keyphrases
- atrial fibrillation
- patients undergoing
- oral anticoagulants
- catheter ablation
- left atrial
- chronic kidney disease
- left atrial appendage
- direct oral anticoagulants
- venous thromboembolism
- end stage renal disease
- cardiovascular disease
- heart failure
- social media
- health information
- percutaneous coronary intervention
- type diabetes
- healthcare
- coronary artery disease
- left ventricular